
Loading, please wait...

Loading, please wait...

Recent research introduces a psychological breakthrough in occupational health through the Health Impairment Grief Scale (HIGS). This tool specifically measures health loss-related grief among employees on long-term sick leave. Often, clinicians might mistake these reactions for clinical depression or anxiety. However, this study proves that grief over lost physical or mental health is a distinct psychological phenomenon. Consequently, understanding this distinction is crucial for Indian medical professionals managing rising workplace stress levels and chronic illness cases.
Furthermore, the HIGS helps rehabilitation professionals differentiate between distinct emotional responses. The 10-item scale provides a structured way to assess how sickness absence impacts an employee's sense of self. During the psychometric evaluation of 226 sick-listed employees, researchers found the scale to be remarkably robust. Specifically, the items showed clear differentiation from symptoms of clinical depression. Therefore, doctors can use this tool to identify patients who require support for mourning their previous state of health rather than standard mood disorders.
Moreover, the HIGS highlights the link between current health loss and anticipated work-related losses. Employees often worry about their future career path while recovering from chronic conditions. By addressing these interconnected emotional challenges, specialists can create more effective rehabilitation plans. This comprehensive approach addresses both the physical recovery and the psychological mourning process. Ultimately, recognizing health loss-related grief enables a more empathetic and successful return to the workforce, reducing the risk of long-term disability.
It refers to the emotional reaction and mourning process an individual experiences due to the loss of their health, physical abilities, or professional identity following a sickness or injury.
The scale allows clinicians to identify specific grief reactions that general depression screenings might miss, ensuring that patients receive tailored psychological support during their recovery and return-to-work journey.
Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.
References
van Eersel JHW et al. Health loss-related grief among sick-listed employees: development and validation of the health impairment grief scale. Disabil Rehabil. 2026 Feb 06. doi: 10.1080/09638288.2026.2624530. PMID: 41646007.
ADP Research Institute. People at Work 2023: A Global Workforce View. 2023.
World Health Organization. Mental Health in the Workplace. 2022.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


New Health Impairment Grief Scale (HIGS) validates health loss-related grief as a distinct psychological phenomenon in sick-listed employees. Learn more....
8 months ago

A retrospective cohort study of 7,716 ICU patients from the MIMIC-IV database demonstrates that Gradient Boosting Decision Trees significantly outperform traditional SOFA scores in predicting in-hospital mortality among patients with sepsis and diabetes, with SHAP analysis providing clinical interpretability.
Today

Occult maternal malignancy accounts for 3.82% of persistent unreportable NIPT results with genomic noise. Multiple chromosomal aberrations, notably on chromosome 18, warrant thorough oncological evaluation and whole-body MRI to ensure timely maternal diagnosis while preserving fetal care.
Today

This article reviews the forensic and clinical complexities of acute myocarditis arising on left ventricular hypertrophy in children, highlighting early diagnostic red flags and multidisciplinary postmortem autopsy protocols.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday